Contracts & Grants

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member's name and school(s) appointments at The University of Texas Health Science Center at Houston, contracting or granting agency, funding amount and project title.

New

Noriaki Aoki, School of Health Information Sciences (SHIS), St. Luke’s International Hospital (Tokyo, Japan), $15,682, Research Scholarship for Dr. Gen Shimada.

Ben J. Barnett, Medical School (MS), Hoffmann Laroche Inc., $164,229, A Randomized, Multi-Center, Double-Blinded, Phase IV Study Comparing the Safety and Efficacy of Pegasys 180 mg Plus Copegus 1000 (<75 kg) or 1200 mg (>=75 kg) to the Currently Approved Combination of Pegasys 180 mg Plus Copegus 800 mg in Interferon-Naive Patients.

Elmer Victor Bernstam, SHIS, Rice University, $51,615, Keck Fellowship, Len Tanaka.

Eugene Boisaubin, MS, American Medical Association Foundation, $15,000, Medical Education Research Consortium Planning Grant.

Michael E. Brandt, SHIS and Graduate School of Biomedical Sciences (GSBS), National Institutes of Health (NIH), $1,746,776, Pediatric Study Center for National Brain Neuroimaging Database.

Henry S. Brown III, School of Public Health (SPH), UT Pan American, $29,723, Access and Utilization of Complementary and Alternative Medicine by Minorities.

Victor Cardenas, SPH, Thrasher Research Fund, $364,759, Randomized Field Intervention Trial of H. Pylori Eradication to Reduce Iron Deficiency Among Children in El Paso, Texas.

Herbert L. Dupont, MS, SPH and GSBS, Optimer Pharmaceuticals Inc., $2,332,851, A Multi-Center, Double-Blind, Randomized Study to Compare the Safety and Efficacy of Prulifloxacin vs. Placebo in the Treatment of Adults with Acute Gastroenteritis in Travelers, Phase III; and Iomai Corporation, $1,479,550, A Phase II Double- Blind, Randomized, Placebo-Controlled Study to Evaluate the Epidemiology of Natural Infection with Enterotoxigenic Escherichia Coli Occuring after Transcutaneous Immunization in a Field Setting.

Joan C. Engebretson, School of Nursing (SON), Stephen F. Austin State University, $33,076, Partners in Living: Theory of Planned Behavior as a Family Intervention Strategy to Influence Breast Cancer Screening Behavior of Latina Immigrants.

Kevin W. Finkel, MS, Veterans Administration Medical Center, $1,040,821, Intensive vs. Conventional Renal Support in Acute Renal Failure: Acute Renal Failure Trial Network (ATN) Study.

Catherine M. Flaitz, Dental Branch (DB), Discus Dental Inc., $11,700, Effects of Whitening Agent with Amorphous Calcium Phosphate and Fluoride, and Whitening Agent with Potassium Nitrate and Fluoride on Enamel Caries-Like Lesion Formation and Progression in Vitro.

Adelaide A. Hebert, MS, Biomedical Development Corporation, $27,240, Novel Topical Treatment for Post-Herpetic Neuralgia; Astellas Pharma US Inc., $80,000, APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Longterm Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis; and Biomedical Development Corporation, $21,482, Novel Topical Treatment of Eczema.

James E. Hixson, SPH and GSBS, Wake Forest University, $672,438, SNPS and Extent of Atheroslerosis (SEA) Study.

Keith Hoots, MS and GSBS, Baylor College of Medicine, $33,076, Platelets as Modifiers of Phenotype in Hemophilia A; and Centers for Disease Control and Prevention, $3,525,000, Prevention of the Complications of Hemophilia through Hemophilia Treatment Centers in Region VI: Prevention of Complications of Bleeding Disorders.

Philip C. Johnson, MS, Tanox Inc., $274,828, A Phase II, Multi- Center, Randomized, Double-Blinded, Placebo-Controlled, Three- Arm Study of the Anti-CD4 Monoclonal Antibody TNX-355 with Optimized Background Therapy in Treatment-Experienced Subjects Infected with HIV-1.

Susan C. King, MS, Reach Out and Read National Center, $70,000, Reach Out and Read Texas.

Theresa M. Koehler, MS and GSBS, The University of Texas Medical Branch at Galveston, $25,994, Computational and Structural Biology in Biodefense/Structure and Function of Atxa, the Bacillus Anthracis Virulence Gene Regulator.

Yahuan Lou, DB and GSBS, NIH, $1,232,550, CD8+ Cells and Ovarian Functions.

Flavia Nelson, MS, Novartis Pharmaceuticals Corp., $339,484, A 24-Month, Double-Blind, Randomized, Multi-Center, Placebo- Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 0.5 mg and 1.25 mg Fingolimod (FTY720) Administered Orally Once Daily vs. Placebo in Patients with Relapsing-Remitting Multiple Sclerosis.

Luis Ostrosky-Zeichner, MS, Pfizer Inc., $71,550, In Vivo Activity of Anidulafungin against Fluconazole-Resistant C. Krusei.

Andrew C. Papanicolaou, MS, University of Houston, $305,019, Texas Center for Learning Disabilities.

Ruben E. Quiros, MS, Emmes Corporation, $3,100, Studies of Pediatric Liver Transplantation (SPLIT).

Mya C. Schiess, MS, Teva Pharmaceutical Industries Ltd., $408,176, A Multi-Center, Double-Blind, Randomized Start, Placebo-Controlled, Parallel-Group Study to Test Rasagiline as a Disease-Modifying Therapy in Early Parkinson’s Disease Subjects.

Didier Sciard, MS, Life-Tech Inc., $6,463, Efficacy of a Newly Developed Catheter for Continuous Nerve Block Anesthesia.

Kimberly C. Smith, MS, Cambridge Systems Inc., $54,036, Saliva Research Project in TB Patients.

Patrick M. Tarwater, SPH, Johns Hopkins University, $25,340, Mechanisms of HIV-Induced PNS Disease: The SIV Macaque Model.

Charles T. Van Buren, MS, Wyeth Pharmaceuticals, $672,438, A Randomized, Open-Label, Comparative Evaluation of the Safety and Efficacy of Sirolimus vs. Cyclosporine when Combined in a Regimen Containing Basiliximab, Mycophenolate Mofetil and Corticosteroids in Primary De Novo Renal Allograft Recipients.

Edward T. Yeh, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM) and GSBS, NIH, $99,224, Role of SENP1 in Prostate Cancer Pathogenesis.

Jiajie Zhang, SHIS, Rice University, $46,448, Keck Fellowship, Jung Wei Chen.

Z. Hong Zhou, MS and GSBS, Centocor Inc., $192,702, Cryoem Imaging of Centocor Molecular Complexes.

Renewal

Rena Sue Day, SPH, Paso Del Norte Health Foundation, $319,790, Que Sabrosa Vida Nutrition Initiative.

Gerard E. Francisco, MS, Allergan Inc., $85,000, Residency Rotation in Interventional Psychiatry.

Steven H. Kelder, SPH, Texas Department of State Health Services, $674,983, Diffusion of CATCH in Texas Elementary Schools.

Shih Ning Liaw, MS, Texas Department of State Health Services, $166,000, C.H.O.S.E.N. Program.

Maria T. Morandi, SPH, Mickey Leland National Urban Air Toxics Research Center, $400,901, Houston Exposure to Air Toxics Study (HEATS), Phase 1.

Hope Northrup, MS and GSBS, Texas Department of State Health Services, $856,896, Comprehensive Metropolitan and Outreach Genetic Services.

John D. Reveille, MS and GSBS, Oregon Health Sciences University, $147,627, Analysis of Genetic Susceptibility to Anterior Uveitis.

Maureen Sanderson, SPH, Texas Cancer Council, $263,711, Partnership Between the Texas Cancer Registry and the UT School of Public Health Brownsville Regional Campus for Assuring Timely, Complete and Accurate Cancer Data in the Lower Rio Grande Valley of Texas.

Supplemental

Roberto C. Arduino, MS, Social & Scientific Systems Inc., $1,381,486, Community Programs for Clinical Research on AIDS (Smart Study - Houston AIDS Research Team).

Lenard M. Lichtenberger, MS and GSBS, Baylor College of Medicine, $418,199, Center for Gastrointestinal Development, Infection and Injury.

Transfer

Richard K. Frye, MS, NIH, $649,920, Developmental Phonological Dyslexia: Neural Mechanisms.